Flow cytometry using the monoclonal antibody CD10-Pe/Cy5 is a useful tool to identify follicular lymphoma cells
Authors:
- E. RubiolERE. Rubiol
- J. UbedaJUJ. Ubeda
- O. LopezOLO. Lopez
- C. EstivillCEC. Estivill
- M. J. CarnicerMCM. J. Carnicer
- L. MunozLML. Munoz
- R. BordesRBR. Bordes
- J. SierraJSJ. Sierra
- J. NomdedeuJNJ. Nomdedeu
- 1 February 2001
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 66 (2) , 100-106
Abstract
Follicular lymphoma (FL) is a specific entity defined by characteristic histology, phenotype and molecular rearrangements. Classically, reactivity for CD19, CD10, and strong positivity for the surface light chain immunoglobulin (SIg) are considered to be phenotypic signs typically expressed in FL. In practice, this pattern is difficult to identify since most neoplastic cells analysed by flow cytometry (FC) show weak intensity for CD19-Pe/Cy5 and for SIg and negativity for CD10-FITC. We used triple antigen combinations including two monoclonal antibodies (MoAbs) against CD10 (CD10-FITC and CD10-Pe/Cy5) and a long-distance polymerase chain reaction (PCR) approach to establish the phenotypic pattern of neoplastic cells carrying t(14;18)(q32;q21). Neoplastic cells showed the following immunophenotype: stronger reactivity against CD20 than against CD19, positivity for CD22 and SIg and negativity for CD5, CD11c and CD10-FITC. Characteristically, CD10-Pe/Cy5 was expressed in all the samples with positive bcl-2/JH rearrangements. In FL, there was a high correlation between histologic diagnosis and reactivity against CD10-Pe/Cy5 (96% cases). In diffuse large cell lymphomas (DLCL), CD10-Pe/Cy5 identified positive cases with t(14;18)(q32;q21) chromosomal translocation, whereas Burkitt lymphomas showed all cases reactivity against CD10-Pe/Cy5. In conclusion, CD10-Pe/Cy5 is a useful antibody for identifying neoplastic cells carrying t(14;18)(q32;q21) in FL and DLCL. In combination with other MoAbs, anti-CD10 (HI10a, Cy-Chrome) can be used to identify a characteristic phenotypic profile of FL against other lymphoproliferative disorders.Keywords
This publication has 25 references indexed in Scilit:
- t(14;18), a journey to eternityLeukemia, 1997
- New type of t(14; 18) in a non-Hodgkin's lymphoma provides insight in molecular events in early B-cell differentiationBritish Journal of Haematology, 1995
- Regulators of cell deathTrends in Genetics, 1995
- Detection of t(14;18) in British follicular lymphoma using cytogenetics, Southern blotting and the polymerase chain reactionBritish Journal of Haematology, 1995
- Diagnostic value of clonality of surface immunoglobulin light and heavy chains in malignant lymphoproliferative disordersAmerican Journal of Hematology, 1993
- The 14;18 translocation in European cases of follicular lymphoma: comparison of Southern blotting and the polymerase chain reactionBritish Journal of Haematology, 1990
- Characterization of the common acute lymphoblastic leukaemia antigen (CD10) as an activation molecule on mature human B cellsClinical and Experimental Immunology, 1990
- Morphology and immunology of circulating cells in leukaemic phase of follicular lymphoma.Journal of Clinical Pathology, 1988
- Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma.Proceedings of the National Academy of Sciences, 1986
- Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas.Journal of Experimental Medicine, 1986